Serina Therapeutics Inc (SER)
undefined
undefined%
At close: undefined
4.79
-0.70%
After-hours Jan 07, 2025, 08:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -14.80M -2.68M -1.26M -10.39M -12.15M -7.50M -6.58M -15.49M
Depreciation & Amortization 131.00K 61.27K 33.37K 1.25M 951.00K 535.00K 682.00K 845.00K
Stock-Based Compensation n/a 7.11K 82.94K n/a n/a n/a n/a n/a
Other Working Capital 1.23M 153.50K -1.61M -612.00K -347.00K -413.00K 187.00K 124.00K
Other Non-Cash Items 6.25M 148.25K -122.21K 3.74M 3.42M -793.00K -388.00K 5.42M
Deferred Income Tax n/a 401.79K -225.38K n/a n/a n/a n/a n/a
Change in Working Capital 625.00K -11.94K -754.79K -260.00K -410.00K 211.00K 776.00K 1.31M
Operating Cash Flow -7.80M -2.08M -2.25M -7.82M -10.16M -8.00M -6.29M -8.43M
Capital Expenditures n/a -9.68K -108.43K -20.00K -641.00K -1.89M -1K -23.00K
Acquisitions n/a n/a 466.00K n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a -666.00K n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a 990.62K 931.75K n/a 354.00K 3.21M n/a n/a
Other Investing Acitivies -10.00M n/a 200.00K n/a -74.00K 5.00K 6.00K -5.00K
Investing Cash Flow -10.00M 980.94K 823.32K -20.00K -361.00K 1.33M 5.00K -28.00K
Debt Repayment n/a 1.31M -12.91K n/a 1.76M n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 17.50M n/a 1.09M 5.96M n/a n/a 1.30M 4.81M
Financial Cash Flow 17.50M 1.31M 1.08M 5.96M 6.26M 6.00M 13.28M 7.25M
Net Cash Flow -300.00K 217.38K -350.21K -1.82M -4.36M -668.00K 7.12M -1.20M
Free Cash Flow -7.80M -2.09M -2.36M -7.84M -10.80M -9.89M -6.29M -8.45M